2 patents
Utility
CorrectedAntibodies Specific to CTLA-4 and Uses Thereof
27 Apr 23
Disclosed herein are anti-CTLA-4 antibodies possessing superior binding and biological activities relative to ipibmumab and tremelimumab, pharmaceutical compositions comprising such.
Ami Navon, Aviv Boim, Ariel Stanhill, Leehee Weinberger, Yuval Avnir
Filed: 20 Sep 19
Utility
Antibodies Specific to CTLA-4 and Uses Thereof
18 Nov 21
Disclosed herein are anti-CTLA-4 antibodies possessing superior binding and biological activities relative to ipibmumab and tremelimumab, pharmaceutical compositions comprising such.
Ami Navon, Aviv Boim, Ariel Stanhill, Leehee Weinberger, Yuval Avnir
Filed: 20 Sep 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first